ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,303.27
0.12%
Dow Jones
40,003.59
0.34%
US Dollar vs MXN
16.6086
0.00%
Brent Oil
83.76
0.00%
Bitcoin
67,226.69
0.22%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. FSD Pharma Inc (HUGE)

  7. FSD Pharma Inc (HUGE) Noticias

HUGE

FSD Pharma (HUGE)

FSD Pharma Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:HUGE
FechaHoraFuenteTítuloSímboloCompañía
16/05/202407:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:HUGEFSD Pharma Inc
11/01/202412:10GlobeNewswire Inc.GBB Maintains Strong Position in its Ongoing Lawsuit with FSD Pharma After Court Refuses to Dismiss CaseNASDAQ:HUGEFSD Pharma Inc
04/01/202423:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:HUGEFSD Pharma Inc
18/12/202311:31Edgar (US Regulatory)Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]NASDAQ:HUGEFSD Pharma Inc
22/09/202305:00GlobeNewswire Inc.InvestmentPitch Media Video Discusses FSD Pharma’s Continued Development of its Exciting New Rapid Detox Drink UNBUZZD™, with Video Comments from Kevin HarringtonNASDAQ:HUGEFSD Pharma Inc
25/08/202317:16Business WireFSD Pharma Rebuts Claims of GBB Drink Lab now acquired by Jupiter Wellness Inc. Trading under the symbol (NASDAQ: JUPW)NASDAQ:HUGEFSD Pharma Inc
03/08/202305:00GlobeNewswire Inc.InvestmentPitch Media Video Features FSD Pharma’s Definitive Agreement Granting Exclusive Rights for Launch of UNBUZZD, a Revolutionary Rapid Alcohol Detoxification DrinkNASDAQ:HUGEFSD Pharma Inc
17/07/202316:00Business WireArbitration Panel Finds that Syneos Health (NASDAQ: SYNH) Failed to Use Commercially Reasonable Efforts in Conducting its Trial for FSD 201NASDAQ:HUGEFSD Pharma Inc
10/07/202306:30Business WireFSD Pharma Retains Christian Attar Law and Team of Experts to Lead Preliminary Investigation of Possible Naked Short Selling and Manipulation in its stockNASDAQ:HUGEFSD Pharma Inc
04/07/202309:00Business WireFSD Pharma Appoints Zeeshan Saeed as Chief Executive Officer, Anthony Durkacz to Serve as Executive Co-Chairman of the Board of DirectorsNASDAQ:HUGEFSD Pharma Inc
30/06/202307:30Business WireFSD Pharma Inc. Announces Results of Annual General and Special Meeting of ShareholdersNASDAQ:HUGEFSD Pharma Inc
23/06/202305:00GlobeNewswire Inc.InvestmentPitch Media Video Discusses FSD Pharma’s Granting of Exclusive Rights to Revolutionary Recreational Alcohol Misuse Technology to Celly NutritionNASDAQ:HUGEFSD Pharma Inc
21/06/202306:03PR Newswire (Canada)DR. RAZA BOKHARI, FORMER EXECUTIVE CHAIRMAN AND CEO OF FSD PHARMA, FILES TWO ADDITIONAL CLAIMS AGAINST THE COMPANY SEEKING RELIEF AND MONETARY DAMAGES EXCEEDING $30.2 MILLIONNASDAQ:HUGEFSD Pharma Inc
20/06/202306:30Business WireFSD Pharma Announces Agreement to Grant Exclusive Rights to Revolutionary Recreational Alcohol Misuse TechnologyNASDAQ:HUGEFSD Pharma Inc
25/05/202306:30Business WireFSD Pharma Appoints Former Ontario Minister of Health Doctor Eric Hoskins to Board of DirectorsNASDAQ:HUGEFSD Pharma Inc
16/05/202305:00GlobeNewswire Inc.InvestmentPitch Media Video Discusses FSD Pharma’s Cost Award of $2.81 Million from Dr. Raza Bokhari in an Arbitration SettlementNASDAQ:HUGEFSD Pharma Inc
12/05/202316:00Business WireFSD Pharma Announces Receipt of Court Action and Update on Spin-Out and DistributionNASDAQ:HUGEFSD Pharma Inc
11/05/202306:30Business WireFSD Pharma Awarded $2.81 Million in Cost Awards From Dr. Raza BokhariNASDAQ:HUGEFSD Pharma Inc
10/05/202306:30Business WireFSD Pharma Completes Dosing of First Cohort in Phase I Clinical Trial of Lucid-MS, a New Drug Candidate for the Treatment of Multiple Sclerosis: Safety Review Committee Recommends Commencing Dosing of Second CohortNASDAQ:HUGEFSD Pharma Inc
08/05/202307:50Business WireFSD Pharma to Present at Sidoti Virtual Investor Conference May 10-11NASDAQ:HUGEFSD Pharma Inc
17/04/202308:00Business WireFSD Pharma Achieves Milestone in Completion of Dosing of Sentinel Subjects in First-in-Human Clinical Trial of Lucid-MS (Lucid-21-302) for Multiple SclerosisNASDAQ:HUGEFSD Pharma Inc
12/04/202307:30Business WireFSD Pharma Announces Plan to Spin-Out Subsidiary as Distribution to Shareholders; Shareholder Meeting Scheduled for June 29, 2023NASDAQ:HUGEFSD Pharma Inc
31/03/202319:00Business WireFSD Pharma Announces Filing of Year-End 2022 ResultsNASDAQ:HUGEFSD Pharma Inc
30/03/202307:30Business WireFSD Pharma Adds Former Celsius Holdings CEO Gerry David to Board of AdvisorsNASDAQ:HUGEFSD Pharma Inc
22/03/202307:30Business WireFSD Pharma Announces Its Australian Entity Receives Approval to Proceed With Phase 1 Clinical Trial of Lucid-201, a Candidate for the Potential Treatment of Major Depressive DisorderNASDAQ:HUGEFSD Pharma Inc
14/03/202307:30Business WireFSD Pharma (Symbol: HUGE) Renews Shareholder Intelligence Services to Investigate Possible Naked Short Selling and Appeals to The Regulators and Oversight Bodies to Look Into The Short Selling Activity Of Its StockNASDAQ:HUGEFSD Pharma Inc
01/03/202305:00GlobeNewswire Inc.InvestmentPitch Media Video Discusses FSD Pharma’s Addition of Kevin Harrington, Author, “Shark Tank” Original, and Infomercial Pioneer to its Advisory BoardNASDAQ:HUGEFSD Pharma Inc
28/02/202307:30Business WireOriginal “Shark” and Iconic Entrepreneur Kevin Harrington Joins FSD Pharma Advisory BoardNASDAQ:HUGEFSD Pharma Inc
21/02/202301:30Business WireFSD Pharma Presenting Two Scientific Posters on Preclinical Toxicology and Efficacy Data of Lucid-21-302 (Lucid-MS) at Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) 2023 ForumNASDAQ:HUGEFSD Pharma Inc
15/02/202306:30Business WireFSD Pharma Regains Compliance with NASDAQ Continued Listing RequirementsNASDAQ:HUGEFSD Pharma Inc
 Showing the most relevant articles for your search:NASDAQ:HUGE

Su Consulta Reciente

COIN
GUIDEGBP
LSE
BB90
NASDAQ
SHOR
NYSE
ENBA
Enbridge
NASDAQ
LEMIX
LSE
53DH
Int.fin. 61
NASDAQ
FRIFFX
Nasdaq Dividend Achiever...
BIT
SNIOL5
Societe Generale Effekten
LATK
AMPLUSDT
Ampleforth
CSE
HZ.WT
Hertz Energy
AQSE
EMQQ.GB
HANetf ICAV
EU
C299S
C299S
AQSE
DUKE.GB
Duke Capital
LSE
76TU
Euro.bk. 24
EU
S425S
S425S
EU
BEAR00535409
Aspa Biond
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados